LG Life Sciences is one the early pioneers of innovative drug development in Korea with a diversified portfolio of chemical drugs, vaccines, biosimilars, biologics, and dermo-cosmetics. Its president, Dr Son, explains the reason why he joined the company, his strategy to turn it into a truly global entity, and its new areas of focus. Dr Son shares his advice to local companies wanting to reach the global stage.
LG Life Sciences, and all other Korean pharma companies for that matter, should be global players and should not be content with the current 1.5 percent share of the global pharmaceutical market
